Semaglutide used once weekly is bound to albumin in the blood allowing for a longer effect or once weekly dosing
Bottom line: Moving your Zepbound dose up by two days is a safe and common practice for managing lifestyle needs, provided you maintain at least 72 hours between your injections
Schedule: One subcutaneous injection a week across an 816 week course, with the dose raised in phases
Weeks 1-4 (2.5mg): establish baseline habits This is your learning phase
Other evidence-based interventions include: Optimising management of associated conditions such as diabetes, hypertension, and dyslipidaemia Coffee consumption, which observational studies associate with reduced liver disease progression Avoiding hepatotoxic medications when possible Regular monitoring through your GP is essential
A study of patients with non-alcoholic fatty liver disease (NAFLD) revealed that giving 300 mg of glutathione daily for four months resulted in significant reductions in elevated ALT (an enzyme associated with liver damage), triglycerides, and ferritin